APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy
Open Access
- 29 October 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (10) , e0224408
Abstract
African polymorphisms in the gene for Apolipoprotein L1 (APOL1) confer a survival advantage against lethal trypanosomiasis but also an increased risk for several chronic kidney diseases (CKD) including HIV-associated nephropathy (HIVAN). APOL1 is expressed in renal cells, however, the pathogenic events that lead to renal cell damage and kidney disease are not fully understood. The podocyte function of APOL1-G0 versus APOL1-G2 in the setting of a known disease stressor was assessed using transgenic mouse models. Transgene expression, survival, renal pathology and function, and podocyte density were assessed in an intercross of a mouse model of HIVAN (Tg26) with two mouse models that express either APOL1-G0 or APOL1-G2 in podocytes. Mice that expressed HIV genes developed heavy proteinuria and glomerulosclerosis, and had significant losses in podocyte numbers and reductions in podocyte densities. Mice that co-expressed APOL1-G0 and HIV had preserved podocyte numbers and densities, with fewer morphologic manifestations typical of HIVAN pathology. Podocyte losses and pathology in mice co-expressing APOL1-G2 and HIV were not significantly different from mice expressing only HIV. Podocyte hypertrophy, a known compensatory event to stress, was increased in the mice co-expressing HIV and APOL1-G0, but absent in the mice co-expressing HIV and APOL1-G2. Mortality and renal function tests were not significantly different between groups. APOL1-G0 expressed in podocytes may have a protective function against podocyte loss or injury when exposed to an environmental stressor. This was absent with APOL1-G2 expression, suggesting APOL1-G2 may have lost this protective function.Keywords
All Related Versions
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK108329)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK097836)
This publication has 38 references indexed in Scilit:
- APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated NephropathyJournal of the American Society of Nephrology, 2011
- APOL1 Localization in Normal Kidney and Nondiabetic Kidney DiseaseJournal of the American Society of Nephrology, 2011
- Identification of the Nephropathy-Susceptibility Locus HIVAN4Journal of the American Society of Nephrology, 2011
- The APOL1 Gene and Allograft Survival after Kidney TransplantationAmerican Journal of Transplantation, 2011
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- Transgenic and Infectious Animal Models of HIV-Associated NephropathyJournal of the American Society of Nephrology, 2009
- HIV-1 Genes vpr and nef Synergistically Damage Podocytes, Leading to GlomerulosclerosisJournal of the American Society of Nephrology, 2006
- Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathyKidney International, 2005
- Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression.Journal of Clinical Investigation, 1997